Orchid Pharma Limited has announced the schedule for its Analysts/Investors Earnings Call to discuss the financial performance for the Quarter-III of Financial Year 2025-26, which ended on December 31, 2025. The call is scheduled to be held on Thursday, February 12, 2026, at 04:30 P.M. (IST). The company's management, including Managing Director Mr. Manish Dhanuka, Whole Time Director Mr. Mridul Dhanuka, and Chief Financial Officer Mr. Sunil Kumar Gupta, will be present to address queries. Systematix Institutional Equities is hosting the call. Details for joining the call, including dial-in numbers and a Diamond Pass registration link, have been provided. The information will also be available on the company's website, www.orchidpharma.com. The company noted that the schedule may be subject to change due to unforeseen circumstances.
